PCNA and neoplasm: Here, A17pro also significantly suppressed tumor growth, which was again associated with lower numbers of PCNA‐ and pERK1/2‐positive cells in the treated tumor xenografts, as well as reduced levels of serum human sIL‐6R (Fig 7J–O, Appendix Fig S3).